Tisdag 26 Maj | 20:32:35 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2027-02-24 08:30 Bokslutskommuniké 2026
2026-11-11 08:30 Kvartalsrapport 2026-Q3
2026-08-26 08:30 Kvartalsrapport 2026-Q2
2026-05-28 N/A X-dag ordinarie utdelning BPCINS 0.00 SEK
2026-05-26 N/A Årsstämma
2026-05-06 - Kvartalsrapport 2026-Q1
2026-02-26 - Bokslutskommuniké 2025
2025-11-12 - Kvartalsrapport 2025-Q3
2025-08-27 - Kvartalsrapport 2025-Q2
2025-05-30 - X-dag ordinarie utdelning BPCINS 0.00 SEK
2025-05-28 - Årsstämma
2025-05-07 - Kvartalsrapport 2025-Q1
2025-02-26 - Bokslutskommuniké 2024
2025-02-12 - Extra Bolagsstämma 2024
2024-11-14 - Kvartalsrapport 2024-Q3
2024-08-28 - Kvartalsrapport 2024-Q2
2024-05-29 - X-dag ordinarie utdelning BPCINS 0.00 SEK
2024-05-28 - Årsstämma
2024-05-06 - Kvartalsrapport 2024-Q1
2024-02-28 - Bokslutskommuniké 2023
2023-11-16 - Kvartalsrapport 2023-Q3
2023-08-29 - Kvartalsrapport 2023-Q2
2023-05-26 - X-dag ordinarie utdelning BPCINS 0.00 SEK
2023-05-25 - Årsstämma
2023-05-04 - Kvartalsrapport 2023-Q1
2023-02-21 - Bokslutskommuniké 2022
2022-11-11 - Kvartalsrapport 2022-Q3
2022-08-16 - Kvartalsrapport 2022-Q2
2022-05-30 - X-dag ordinarie utdelning BPCINS 0.00 SEK
2022-05-27 - Årsstämma
2022-05-06 - Kvartalsrapport 2022-Q1
2022-02-22 - Bokslutskommuniké 2021

Beskrivning

LandSverige
ListaSpotlight
SektorInformationsteknik
IndustriElektronisk utrustning
BPC Instruments är verksamt inom bioteknik. Bolaget säljer och utvecklar automatiserade analysverktyg som används vid bioteknisk analys. Produktlinjen är centrerad kring system som mäter gasvolym, gasflödeshastighet och utsläpp. Utöver är bolaget verksamt inom sektorer så som biologisk nedbrytbarhet, djur- och människonäring och avloppsvattenbehandling. BPC Instruments grundades 2005 och har sitt huvudkontor i Lund.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-05-26 17:15:00

The following resolutions were passed at the Annual General Meeting (the "AGM") of BPC Instruments AB (publ) (the "Company") on 26 May 2026 in Lund.

Adoption of income statement and balance sheet and discharge from liability
The AGM resolved to adopt the income statement and balance sheet for the Company for the financial year 2025. The members of the Board of Directors and the CEO were discharged from liability for the financial year 2025.

Allocation of profit or loss
The AGM resolved, in accordance with the Board of Directors' proposal, that the Company's results for the financial year 2025 shall be carried forward and that no dividend shall be paid.

Board of Directors and auditor
The AGM resolved, in accordance with the shareholders' proposal, on re-election of Gustaf Olsson, Jing Liu and Kristofer Cook and new election of Johan Hallberg as Board members. Gustaf Olsson was re-elected as the Chairman of the Board of Directors. The AGM further re-elected the audit firm Öhrlings PricewaterhouseCoopers AB as auditor.

The AGM further resolved on remuneration to the Board of Directors in accordance with the shareholders' proposal. The AGM also resolved, in accordance with the shareholders' proposal, that remuneration to the auditor shall be paid in accordance with approved invoice.

Resolution on issue authorization
The AGM resolved, in accordance with the Board of Directors' proposal, to authorize the Board of Directors to, on one or several occasions during the period up to the next AGM, resolve on a new issue of shares, warrants or convertibles. Such issue resolution may be made with or without deviation from the shareholders' pre-emption rights and with or without provision for contribution in kind, set-off, or other conditions. The total number of shares that may be issued, or, in the event of an issue of warrants or convertibles, any additional shares after exercise of any warrant or conversion, pursuant to the authorization, shall be limited to 20 percent of the number of outstanding shares in the Company as per the day of the notice to the Annual General Meeting 2026.

The purpose of the authorization is to increase the Company's financial flexibility and the Board of Directors' room for action. Should the Board of Directors resolve on a share issue with deviation from the shareholders' pre-emption rights, the reason for this shall be to broaden the ownership structure, procure working capital, increase the liquidity of the share or acquire businesses, or enable the acquiring of capital for acquisitions.

For more information, please contact:
Dr. Jing Liu, CEO
BPC Instruments AB (publ)
Tel: +46 (0) 46 16 39 51
E-mail: [email protected]

About BPC Instruments AB
BPC Instruments is a Swedish technology company developing analytical instruments for renewable bioenergy and environmental biotechnology, including biogas and biodegradability testing. The systems enable advanced testing with higher accuracy and consistency, while reducing the time and manual work required. The portfolio combines high-quality hardware and software with deep application knowledge built over more than 20 years. Today, BPC exports to more than 90 countries and is listed on the Spotlight Stock Market in Sweden. For more information, please visit: www.bpcinstruments.com.